Ig E-mediated immediate-type hypersensitivity to the pyrazolone drug propyphenazone

Journal of Allergy and Clinical Immunology

Volumn 111, Issue 4, 2003, Pages 882-888

  Himly, Martin ^a   Jahn Schmid, Beatrice ^b   Pittertschatscher, Klaus ^a   Bohle, Barbara ^b   Grubmayr, Karl ^c   Ferreira, Fátima ^a   Ebner, Herwig ^d   Ebner, Christof ^a,b,d  

^a UNIVERSITY OF SALZBURG   (Austria)

^b UNIVERSITY OF VIENNA   (Austria)

^c JOHANNES KEPLER UNIVERSITY LINZ   (Austria)

^d Allergy Clinic Reumannplatz   (Austria)

Author keywords

Adverse drug reaction; Anaphylaxis; Drug allergy; ELISA; IgE; Propyphenazone

Indexed keywords

AMINOPHENAZONE; DIPYRONE; IMMUNOGLOBULIN E; NONSTEROID ANTIINFLAMMATORY AGENT; PHENAZONE; PROPYPHENAZONE; PYRAZOLONE DERIVATIVE; DRUG DERIVATIVE;

ADOLESCENT; ADULT; ANAPHYLAXIS; ANGIONEUROTIC EDEMA; ANTIBODY DETECTION; ARTICLE; ASTHMA; DRUG STRUCTURE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMEDIATE TYPE HYPERSENSITIVITY; INTRACUTANEOUS TEST; MAJOR CLINICAL STUDY; MALE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRICK TEST; PRIORITY JOURNAL; RHINITIS; TACHYCARDIA; URTICARIA; VOMITING; DRUG HYPERSENSITIVITY; IMMUNOBLOTTING; IMMUNOLOGY; MIDDLE AGED; SKIN TEST;

ADOLESCENT; ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIPYRINE; DRUG HYPERSENSITIVITY; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; HYPERSENSITIVITY, IMMEDIATE; IMMUNOBLOTTING; IMMUNOGLOBULIN E; MALE; MIDDLE AGED; SKIN TESTS;

EID: 0038439594     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1067/mai.2003.163     Document Type: Article

References (15)

1. Samter M, Beers RF. Intolerance to aspirin. Ann Intern Med 1968;68:975-83.
2. Corominas M. Mechanisms implicated in adverse reactions to nonsteroidal anti-inflammatory drugs. Clin Exp Allergy 1998;28(suppl 4):41-5.
3. Dekker JW, Nizankowska E, Schmitz-Schuhmann M, Pile K, Bochenk G, Dyczek, A et al. Aspirin-induced asthma and HLA-DRB1 and HLA-DPB1 genotypes. Clin Exp Allergy 1997;27:574-7.
4. Demoly P, Bousquet J. Epidemiology of drug allergy. Curr Opin Allergy Clin Immunol 2001;1:305-10.
5. Barraud A, Goncalo M, Bruynzeel D, Bircher A. Guidelines for performing skin tests with drugs in the investigation of cutaneous adverse drug reactions. Contact Dermatitis 2001;45:321-8.
6. Czemiawska-Mysik G, Szczeklik A. Idiosyncrasy to pyrazoline drugs. Allergy 1981;36:381-4.
7. Van der Klauw MM, Wilson JH, Stricker BH. Drug associated anaphylaxis: 20 years of reporting in the Netherlands (1974-1994) and review of the literature. Clin Exp Allergy 1996;26:1341-2.
8. Rubio-Martinez A, Garcia-Erce JA, Salvador C, Gomez-Arteta E, Gimeno JJ. Autoimmune haemolytic anaemia induced by propyphenazone. Vox Sanguinis 1998;75:257.
9. Torrelo A, Soria C, Rocamora A, Ledo A. Propyphenazone-induced serum sickness. Int J Dermatol 1990;29:384-5.
10. Zhu D, Becker WM, Schulz KH, Schubeler K, Schlaak M. Detection of IgE antibodies specific for 1-phenyl-2,3-dimethyl-3-pyrazolidine-5-one by RAST: a serological diagnostic method for sensitivity to pyrazoline drugs. Asian Pac J Allergy Immunol 1992;10:95-101.
11. Quiralte J, Blanco C, Castillo R, Ortega N, Carillo T. Anaphylactoid reactions due to nonsteroidal antiinflammatory drugs: clinical and crossreactivity studies. Ann Allergy Asthma Immunol 1997;78:293-6.
12. Schneider CH, Kasper MF, De Weck AL, Rolli H, Angst D. Diagnosis of antibody-mediated drug allergy. Allergy 1987;42:597-603.
13. Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: a meta analysis of prospective studies. JAMA 1998;279:1200-5.
14. Pouyanne P, Haramburu F, Imbs JL, Bégaud B. Admissions to hospital caused by adverse drug reactions: cross sectional incidence study. Br Med J 2000;320:1036.
15. Gruchalla R. Understanding drug allergy. J Allergy Clin Immunol 2000;105:637-44.